Evidence map›Paper›PMID 38577701›Full record

ArticleJAC-antimicrobial resistance2024

Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres.

Jule Rutz, Jan-Hendrik Naendrup, Caroline Bruns, Annika Y Classen, Jon Salmanton-García, Harald Seifert, Rosanne Sprute, Jannik Stemler, Sarah V Walker, Oliver A Cornely and 3 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03353532 (Staphylococcus Aureus Surgical Site Infection Multinational Epidemiology in Europe), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03353532 completednot on this map

Staphylococcus Aureus Surgical Site Infection Multinational Epidemiology in Europe

TypeobservationalSponsorUniversity of CologneRan2017 to 2021Enrolled178,902ConditionsStaphylococcus Aureus, Wound Infection, Surgical, Epidemiology
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jule RutzUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.ORCID https://orcid.org/0000-0003-4855-2990
Jan-Hendrik NaendrupUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.
Caroline BrunsUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.
Annika Y ClassenUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.
Jon Salmanton-GarcíaUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.ORCID https://orcid.org/0000-0002-6766-8297
Harald SeifertGerman Centre for Infection Research (DZIF), Partner Site Bonn Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0002-7732-4762
Rosanne SpruteUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.ORCID https://orcid.org/0000-0003-2457-6437
Jannik StemlerUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.ORCID https://orcid.org/0000-0001-9152-2469
Sarah V WalkerGerman Centre for Infection Research (DZIF), Partner Site Bonn Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0001-8288-1793
Oliver A CornelyUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.ORCID https://orcid.org/0000-0001-9599-3137
Blasius J LissHELIOS University Clinic of Wuppertal, Department of Haematology, Oncology, Palliative Care and Infectious Disease, Wuppertal, Germany.
Sibylle C MellinghoffUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), Cologne, Germany.ORCID https://orcid.org/0000-0003-3928-2503
SALT study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To assess incidence rates of surgical site infections (SSI) by MRSA and to determine related factors and clinical outcome compared to MSSA, including country-specific, institutional and patient determinants. Patients and methods: We performed a subgroup analysis of the Europe-wide SALT (NCT03353532) study population with MRSA SSI from 14 centres in France, Germany, Italy, Spain and the UK. Results: An overall MRSA SSI incidence of 0.06% ( Conclusions: This study shows low overall and country-specific incidence rates of MRSA SSI in Europe. We could show significant differences between countries as well as between centres with established ABS and ID consultation programmes were observed. The number of those programmes seems too small against this background.

Identifiers

PMID38577701
PMCPMC10993902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.